Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
MOVE logo MOVE
Upturn stock rating
MOVE logo

Movano Inc (MOVE)

Upturn stock rating
$7.21
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

10/20/2025: MOVE (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

1 Analysts rated it

Very few follow this stock; limited insights, higher-risk early investing.

1 Year Target Price $300

1 Year Target Price $300

Analysts Price Target For last 52 week
$300 Target price
52w Low $5.1
Current$7.21
52w High $69.67

Analysis of Past Performance

Type Stock
Historic Profit -59.53%
Avg. Invested days 25
Today’s Advisory PASS
Upturn Star Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance 1.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulation Last Close 10/20/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 6.23M USD
Price to earnings Ratio -
1Y Target Price 300
Price to earnings Ratio -
1Y Target Price 300
Volume (30-day avg) 1
Beta 0.85
52 Weeks Range 5.10 - 69.67
Updated Date 10/20/2025
52 Weeks Range 5.10 - 69.67
Updated Date 10/20/2025
Dividends yield (FY) -
Basic EPS (TTM) -27.7

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -
Operating Margin (TTM) -3165.05%

Management Effectiveness

Return on Assets (TTM) -97.08%
Return on Equity (TTM) -219.6%

Valuation

Trailing PE -
Forward PE -
Enterprise Value 3361892
Price to Sales(TTM) 13.25
Enterprise Value 3361892
Price to Sales(TTM) 13.25
Enterprise Value to Revenue 7.15
Enterprise Value to EBITDA -1.24
Shares Outstanding 834908
Shares Floating 678238
Shares Outstanding 834908
Shares Floating 678238
Percent Insiders 29.65
Percent Institutions 15.02

ai summary icon Upturn AI SWOT

Movano Inc

stock logo

Company Overview

overview logo History and Background

Movano Inc. was founded in 2018 and is focused on developing non-invasive wearable technology to improve the accessibility and affordability of healthcare. They aim to use radio frequency (RF) technology to monitor various health parameters.

business area logo Core Business Areas

  • Medical Devices: Development of wearable devices for continuous health monitoring, including heart rate, sleep, SpO2, respiratory rate and glucose trends using RF technology.

leadership logo Leadership and Structure

The leadership team includes John Mastrototaro as CEO and a board of directors with expertise in medical technology and business development. The company is structured around research and development, engineering, and regulatory affairs.

Top Products and Market Share

overview logo Key Offerings

  • Evie Ring: A smart ring designed for women's health monitoring, targeting the $60 billion women's health market. Competitors include Oura Ring and Fitbit.

Market Dynamics

industry overview logo Industry Overview

The wearable medical device market is experiencing rapid growth, driven by increasing consumer interest in personal health monitoring and advancements in sensor technology. There's a need for non-invasive accurate monitoring of various health parameters.

Positioning

Movano is positioning itself as a leader in non-invasive RF-based health monitoring technology, with a focus on women's health. Their competitive advantage lies in their proprietary RF sensor technology.

Total Addressable Market (TAM)

The total addressable market for wearable health technology is estimated to be in the hundreds of billions of dollars. Movano aims to capture a portion of this market through their Evie Ring and future products.

Upturn SWOT Analysis

Strengths

  • Proprietary RF sensor technology
  • Focus on women's health
  • Potential for non-invasive glucose monitoring

Weaknesses

  • Pre-revenue company
  • Reliance on regulatory approvals
  • Limited market presence compared to established players

Opportunities

  • Partnerships with healthcare providers
  • Expansion into new health monitoring applications
  • Increasing demand for remote patient monitoring

Threats

  • Competition from established wearable device companies
  • Regulatory hurdles
  • Technological advancements by competitors

Competitors and Market Share

competitor logo Key Competitors

  • FIT
  • OURA

Competitive Landscape

Movano faces stiff competition from established players like Fitbit and Oura, which have significant market share and brand recognition. Movano's success depends on differentiating its technology and targeting niche markets.

Growth Trajectory and Initiatives

Historical Growth: Since its founding, Movano's growth has been focused on R&D and clinical studies. There is currently no market revenue.

Future Projections: Future growth depends on obtaining regulatory approvals and commercializing their products, particularly the Evie Ring. Analyst estimates are highly speculative.

Recent Initiatives: Recent initiatives include finalizing the design of the Evie Ring, conducting clinical trials, and engaging with regulatory agencies.

Summary

Movano is a development-stage company focused on innovative health technology. While they have promising technology in RF based health monitoring and a focus on women's health, they face significant challenges in securing regulatory approvals and competing with larger, established companies. Cash burn is a concern as they have no revenue. Future success depends on the successful launch of the Evie Ring and expansion into new applications.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Company website
  • SEC filings
  • Analyst reports

Disclaimers:

This analysis is for informational purposes only and should not be considered financial advice. Investment decisions should be based on individual research and consultation with a qualified financial advisor.

Upturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Movano Inc

Exchange NASDAQ
Headquaters Pleasanton, CA, United States
IPO Launch date 1999-08-05
CEO, President & Director Dr. John Mastrototaro Ph.D.
Sector Healthcare
Industry Medical Devices
Full time employees 32
Full time employees 32

Movano Inc., a technology company, engages in the development of a platform to deliver healthcare solutions at the intersection of medical and consumer devices. It offers Evie Ring, a wearable device for women that combines health and wellness metrics comprising resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, and menstrual symptom tracking, as well as activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking. The company develops System-on-a-Chip (SoC) for blood pressure or continuous glucose monitoring (CGM) systems. It sells its products through its website, retail or other distribution channels, value-added resellers (VARs), as well as partnering with OEMs. The company was formerly known as Maestro Sensors Inc. and changed its name to Movano Inc. in August 2018. Movano Inc. was incorporated in 2018 and is headquartered in Pleasanton, California.